Immunogenicity and safety of a group B Streptococcus vaccine (GBS-AlpN) in pregnant women and their infants: a phase 2, multicentre, observer-blind, randomised, placebo-controlled study.

Heath PT, Zuma-Gwala N, Helmig RB, Horne E, Kjærbye-Thygesen A, Crusell MKW, Nchabeleng M, Strehlau R, Khalil MR, Jones CE, Biccler J, Dimsits J, Johansson-Lindbom B, Fischer PB, Oostvogels L, Madhi SA, MVX0004 study group

Open source

DOI
10.1016/s1473-3099(25)00659-0
Published
2026 May
Container
The Lancet. Infectious diseases
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s1473-3099-25-00659-0,
  title = {Immunogenicity and safety of a group B Streptococcus vaccine (GBS-AlpN) in pregnant women and their infants: a phase 2, multicentre, observer-blind, randomised, placebo-controlled study.},
  author = {Heath PT and Zuma-Gwala N and Helmig RB and Horne E and Kjærbye-Thygesen A and Crusell MKW and Nchabeleng M and Strehlau R and Khalil MR and Jones CE and Biccler J and Dimsits J and Johansson-Lindbom B and Fischer PB and Oostvogels L and Madhi SA and MVX0004 study group},
  year = {2026},
  journal = {The Lancet. Infectious diseases},
  doi = {10.1016/s1473-3099(25)00659-0},
  url = {https://doi.org/10.1016/s1473-3099(25)00659-0}
}

RIS

TY  - JOUR
TI  - Immunogenicity and safety of a group B Streptococcus vaccine (GBS-AlpN) in pregnant women and their infants: a phase 2, multicentre, observer-blind, randomised, placebo-controlled study.
AU  - Heath PT
AU  - Zuma-Gwala N
AU  - Helmig RB
AU  - Horne E
AU  - Kjærbye-Thygesen A
AU  - Crusell MKW
AU  - Nchabeleng M
AU  - Strehlau R
AU  - Khalil MR
AU  - Jones CE
AU  - Biccler J
AU  - Dimsits J
AU  - Johansson-Lindbom B
AU  - Fischer PB
AU  - Oostvogels L
AU  - Madhi SA
AU  - MVX0004 study group
PY  - 2026
JO  - The Lancet. Infectious diseases
DO  - 10.1016/s1473-3099(25)00659-0
UR  - https://doi.org/10.1016/s1473-3099(25)00659-0
ER  - 

APA

PT, H., N, Z., RB, H., E, H., A, K., MKW, C., M, N., R, S., MR, K., CE, J., J, B., J, D., B, J., PB, F., L, O., SA, M., & group, M. S. (2026). Immunogenicity and safety of a group B Streptococcus vaccine (GBS-AlpN) in pregnant women and their infants: a phase 2, multicentre, observer-blind, randomised, placebo-controlled study.. The Lancet. Infectious diseases. https://doi.org/10.1016/s1473-3099(25)00659-0

Source records